VIDAS Testosterone, Ref 30418
Published July 19, 2017 · Recall initiated: May 15, 2017
Summary
FDA records medical device Class II recall Z-2339-2017, published July 19, 2017 and initiated May 15, 2017. Recalling firm: bioMerieux, Inc.; Status: Terminated; Reported quantity: 742; Lot: Lots 1004878310 & 1005001080. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- bioMerieux, Inc.
- Distributor
- AR, CA, CO, GA, IL, IA, MI, MN, MT, NY, OK, TN, TX, WY, Columbia, Costa Rica, El Salvador, France, Hong Kong, Jordan, Nicaragua, Russian Fed., Sri Lanka, Sweden, Ukraine
- Lot
- Lots 1004878310 & 1005001080
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITEK 2 Systems and VITEK 2 with MYLA.May 18, 2022
- FDAVIDAS RUB IgG (RBG), REF 30226January 5, 2022
- FDAVITEK® 2 Systems Software Version 9.01 Update Kit.December 26, 2018
- FDABACT/ALERT VIRTUO system, B Unit, with Version R2.0 Firmware Product Usage: The BacT/ALERT VIRTU MicrobialOctober 31, 2018
- FDAKite Hill Almond Yogurt, Strawberry ,NET WT. 5.3 oz (150G) ; Case UPC: 8-56624-00414-2 Distributed by LyricalJuly 19, 2017
- FDAThe Plum A+ Infusion Systems are a multipurpose family of devices that provides precise delivery of multipleJuly 19, 2017
Questions about this recall
Was VIDAS Testosterone, Ref 30418 recalled?
Yes. FDA published recall Z-2339-2017 on July 19, 2017. Reported hazard: Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.
What should I do if I have this product?
Voluntary: Firm initiated · Letter